Skip to main content
Fig. 2 | Pediatric Rheumatology

Fig. 2

From: Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case series

Fig. 2

Treatments used in primary and secondary pediatric APS patients. A, Various anticoagulant and antiplatelet medications were employed. B, Other notable treatments. LMWH = low molecular weight heparin; UFH = unfractionated heparin; DOAC = direct oral anticoagulant; Fonda. = fondaparinux; HCQ = hydroxychloroquine; Immuno. = immunomodulatory therapy; PLEX = plasmapheresis

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096